drugset / Trial / NCT06593730
Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days
RandomizedParallel-groupDouble-blindBasic science
Summary
The study is being conducted to evaluate the safety and tolerability after single and repeated twice daily intra-anal applications of 1mL NRL001 cream in stepwise increasing concentrations.
Timeline
- Start
- 2007-08
- Primary completion
- 2007-08
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NRL001 | Small molecule | 0.5 % | Other |
| Subject | NRL001 | Small molecule | 0.75 % | Other |
| Subject | NRL001 | Small molecule | 1 % | Other |
| Subject | NRL001 | Small molecule | 1.5 % | Other |
| Subject | NRL001 | Small molecule | 2 % | Other |
| Subject | NRL001 | Small molecule | 2.5 % | Other |
Indications
No indication recorded.